CNE000001CM5
CNE000001CM5
YABAO PHARMACEUTICAL GROUP CO L
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 4.89B EUR | 3.98B EUR | 4.62B EUR | 4.49B EUR |
Enterprise Value | 3.95B EUR | 3.1B EUR | 3.79B EUR | 3.71B EUR |
Valuation Multiples | ||||
Trailing P/E | 15.37x | 14.08x | 16.56x | 16.08x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 2.18x | 2.37x | 2.83x | 2.69x |
Price to Book | 1.73x | 1.41x | 1.62x | 1.56x |
EV/Revenue | 1.76x | 1.85x | 2.33x | 2.22x |
EV/EBITDA | 8.49x | 8.36x | 11.1x | 10.95x |
Price to FCF (P/FCF) | 10.58x | 8.95x | 10.23x | 11.14x |
EV/FCF | 8.54x | 6.96x | 8.4x | 9.19x |
FCF Yield | 9.45% | 11.18% | 9.78% | 8.98% |